Metal Nanoparticles as Targeted Carriers Circumventing the Blood–Brain Barrier

International Review of Neurobiology

Volumn 130, Issue , 2016, Pages 199-227

  Sintov, A C ^a   Velasco Aguirre, C ^b,c   Gallardo Toledo, E ^b,c   Araya, E ^c,d   Kogan, M J ^b,c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b UNIVERSITY OF CHILE   (Chile)

^c University of Chile   (Chile)

^d UNIVERSIDAD ANDRÉS BELLO   (Chile)

Author keywords

Gold nanoparticles; Intranasal route; Magnetic nanoparticles; Transcytosis

Indexed keywords

CERIUM OXIDE NANOPARTICLE; GADOLINIUM METALLOFULLERENE NANOPARTICLE; GOLD NANOPARTICLE; NANOPARTICLE; PLATINUM NANOPARTICLE; SILVER NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; ULTRASMALL GADOLINIUM OXIDE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; ZINC OXIDE NANOPARTICLE; METAL NANOPARTICLE;

ACTIVE TRANSPORT; ADSORPTIVE MEDIATED TRANSCYTOSIS; ALZHEIMER DISEASE; AUTOPHAGY; BLOOD BRAIN BARRIER; FILOBASIDIELLA; HUMAN; HUNTINGTON CHOREA; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; LIPOPHILICITY; NANOTECHNOLOGY; NEUROTOXICITY; NONHUMAN; NOSE SEPTUM; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR MEDIATED TRANSCYTOSIS; TRANSCYTOSIS; ANIMAL; DRUG DELIVERY SYSTEM; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; DRUG DELIVERY SYSTEMS; HUMANS; METAL NANOPARTICLES;

EID: 84994065458     PISSN: 00747742     EISSN: 21625514     Source Type: Book Series    
DOI: 10.1016/bs.irn.2016.06.007     Document Type: Chapter

References (109)

1. Abbott, N.J., Comparative physiology of the blood-brain barrier. Physiology and pharmacology of the blood-brain barrier, 1992, Springer, Berlin, Heidelberg, 371–396.
2. Abbott, N.J., Patabendige, A.A., Dolman, D.E., Yusof, S.R., Begley, D.J., Structure and function of the blood-brain barrier. Neurobiology of Disease 37:1 (2010), 13–25.
3. Afifi, M., Almaghrabi, O.A., Kadasa, N.M., Ameliorative effect of zinc oxide nanoparticles on antioxidants and sperm characteristics in streptozotocin-induced diabetic rat testes. BioMed Research International, 2015, 2015, 153573.
4. Arora, P., Sharma, S., Garg, S., Permeability issues in nasal drug delivery. Drug Discovery Today 7:18 (2002), 967–975.
5. Arvizo, R.R., Giri, K., Moyano, D., Miranda, O.R., Madden, B., McCormick, D.J.,.. Mukherjee, P., Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles. PLoS One, 7(3), 2012, e33650.
6. AshaRani, P.V., Hande, M.P., Valiyaveettil, S., Anti-proliferative activity of silver nanoparticles. BMC Cell Biology, 10, 2009, 65.
7. Becker, N.H., Novikoff, A.B., Zimmerman, H.M., Fine structure observations of the uptake of intravenously injected peroxidase by the rat choroid plexus. The Journal of Histochemistry and Cytochemistry 15:3 (1967), 160–165.
8. Bennewitz, M.F., Lobo, T.L., Nkansah, M.K., Ulas, G., Brudvig, G.W., Shapiro, E.M., Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI. ACS Nano 5:5 (2011), 3438–3446.
9. Bhumkar, D.R., Joshi, H.M., Sastry, M., Pokharkar, V.B., Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharmaceutical Research 24:8 (2007), 1415–1426.
10. Casettari, L., Illum, L., Chitosan in nasal delivery systems for therapeutic drugs. Journal of Controlled Release 190 (2014), 189–200.
11. Chen, N., Shao, C., Li, S., Wang, Z., Qu, Y., Gu, W.,.. Ye, L., Cy5.5 conjugated MnO nanoparticles for magnetic resonance/near-infrared fluorescence dual-modal imaging of brain gliomas. Journal of Colloid and Interface Science 457 (2015), 27–34.
12. Chertok, B., Moffat, B.A., David, A.E., Yu, F., Bergemann, C., Ross, B.D., Yang, V.C., Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 29:4 (2008), 487–496.
13. Corot, C., Robert, P., Idee, J.M., Port, M., Recent advances in iron oxide nanocrystal technology for medical imaging. Advanced Drug Delivery Reviews 58:14 (2006), 1471–1504.
14. 198Au from nasal mucous membrane into cerebrospinal fluid. Acta Oto-Laryngologica 70:1 (1970), 58–61.
15. Day, E.S., Zhang, L., Thompson, P.A., Zawaski, J.A., Kaffes, C.C., Gaber, M.W.,.. West, J.L., Vascular-targeted photothermal therapy of an orthotopic murine glioma model. Nanomedicine (London, England) 7:8 (2012), 1133–1148.
16. Dell'Orco, D., Lundqvist, M., Oslakovic, C., Cedervall, T., Linse, S., Modeling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS One, 5(6), 2010, e10949.
17. Dhuria, S.V., Hanson, L.R., Frey, W.H. 2nd., Intranasal delivery to the central nervous system: Mechanisms and experimental considerations. Journal of Pharmaceutical Sciences 99:4 (2010), 1654–1673.
18. Dilnawaz, F., Sahoo, S.K., Therapeutic approaches of magnetic nanoparticles for the central nervous system. Drug Discovery Today 20:10 (2015), 1256–1264.
19. Dobrovolskaia, M.A., Aggarwal, P., Hall, J.B., McNeil, S.E., Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Molecular Pharmaceutics 5:4 (2008), 487–495.
20. Elder, A., Gelein, R., Silva, V., Feikert, T., Opanashuk, L., Carter, J.,.. Oberdorster, G., Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environmental Health Perspectives 114:8 (2006), 1172–1178.
21. Estevez, A.Y., Pritchard, S., Harper, K., Aston, J.W., Lynch, A., Lucky, J.J.,.. Erlichman, J.S., Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. Free Radical Biology & Medicine 51:6 (2011), 1155–1163.
22. Etame, A.B., Diaz, R.J., O'Reilly, M.A., Smith, C.A., Mainprize, T.G., Hynynen, K., Rutka, J.T., Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound. Nanomedicine (London, England) 8:7 (2012), 1133–1142.
23. Faucher, L., Guay-Begin, A.A., Lagueux, J., Cote, M.F., Petitclerc, E., Fortin, M.A., Ultra-small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI. Contrast Media & Molecular Imaging 6:4 (2011), 209–218.
24. Feng, X., Chen, A., Zhang, Y., Wang, J., Shao, L., Wei, L., Central nervous system toxicity of metallic nanoparticles. International Journal of Nanomedicine 10 (2015), 4321–4340.
25. Fiandra, L., Colombo, M., Mazzucchelli, S., Truffi, M., Santini, B., Allevi, R.,.. Corsi, F., Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice. Nanomedicine (London, England) 11:6 (2015), 1387–1397.
26. Frigell, J., Garcia, I., Gomez-Vallejo, V., Llop, J., Penades, S., 68Ga-labeled gold glyconanoparticles for exploring blood-brain barrier permeability: Preparation, biodistribution studies, and improved brain uptake via neuropeptide conjugation. Journal of the American Chemical Society 136:1 (2014), 449–457.
27. Gabathuler, R., Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiology of Disease 37:1 (2010), 48–57.
28. Gahramanov, S., Muldoon, L.L., Varallyay, C.G., Li, X., Kraemer, D.F., Fu, R.,.. Neuwelt, E.A., Pseudoprogression of glioblastoma after chemo- and radiation therapy: Diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol versus gadoteridol and correlation with survival. Radiology 266:3 (2013), 842–852.
29. Genter, M.B., Newman, N.C., Shertzer, H.G., Ali, S.F., Bolon, B., Distribution and systemic effects of intranasally administered 25 nm silver nanoparticles in adult mice. Toxicologic Pathology 40:7 (2012), 1004–1013.
30. Glat, M., Skaat, H., Menkes-Caspi, N., Margel, S., Stern, E.A., Age-dependent effects of microglial inhibition in vivo on Alzheimer's disease neuropathology using bioactive-conjugated iron oxide nanoparticles. Journal of Nanobiotechnology, 11, 2013, 32.
31. Guerrero, S., Araya, E., Fiedler, J.L., Arias, J.I., Adura, C., Albericio, F.,.. Kogan, M.J., Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide. Nanomedicine (London, England) 5:6 (2010), 897–913.
32. 18F-labeled conjugate gold-nanoparticle-peptide with potential biomedical application. Bioconjugate Chemistry 23:3 (2012), 399–408.
33. Han, D., Tian, Y., Zhang, T., Ren, G., Yang, Z., Nano-zinc oxide damages spatial cognition capability via over-enhanced long-term potentiation in hippocampus of Wistar rats. International Journal of Nanomedicine 6 (2011), 1453–1461.
34. Hanley, C., Thurber, A., Hanna, C., Punnoose, A., Zhang, J., Wingett, D.G., The influences of cell type and ZnO nanoparticle size on immune cell cytotoxicity and cytokine induction. Nanoscale Research Letters 4:12 (2009), 1409–1420.
35. Hanson, L.R., Frey, W.H. 2nd., Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS. Journal of Neuroimmune Pharmacology 2:1 (2007), 81–86.
36. Hanson, L.R., Frey, W.H. 2nd., Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neuroscience, 9(Suppl. 3), 2008, S5.
37. Heckman, K.L., DeCoteau, W., Estevez, A., Reed, K.J., Costanzo, W., Sanford, D.,.. Erlichman, J.S., Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain. ACS Nano 7:12 (2013), 10582–10596.
38. Herve, F., Ghinea, N., Scherrmann, J.M., CNS delivery via adsorptive transcytosis. The AAPS Journal 10:3 (2008), 455–472.
39. Hu, R., Zheng, L., Zhang, T., Gao, G., Cui, Y., Cheng, Z.,.. Hong, F., Molecular mechanism of hippocampal apoptosis of mice following exposure to titanium dioxide nanoparticles. Journal of Hazardous Materials 191:1–3 (2011), 32–40.
40. Hutter, E., Boridy, S., Labrecque, S., Lalancette-Hebert, M., Kriz, J., Winnik, F.M., Maysinger, D., Microglial response to gold nanoparticles. ACS Nano 4:5 (2010), 2595–2606.
41. Illum, L., Transport of drugs from the nasal cavity to the central nervous system. European Journal of Pharmaceutical Sciences 11:1 (2000), 1–18.
42. Illum, L., Nasal drug delivery: New developments and strategies. Drug Discovery Today 7:23 (2002), 1184–1189.
43. Illum, L., Nasal drug delivery: Possibilities, problems and solutions. Journal of Controlled Release 87:1–3 (2003), 187–198.
44. Illum, L., Is nose-to-brain transport of drugs in man a reality?. The Journal of Pharmacy and Pharmacology 56:1 (2004), 3–17.
45. Iv, M., Telischak, N., Feng, D., Holdsworth, S.J., Yeom, K.W., Daldrup-Link, H.E., Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors. Nanomedicine (London, England) 10:6 (2015), 993–1018.
46. Jung, C.W., Jacobs, P., Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, ferumoxtran, ferumoxsil. Magnetic Resonance Imaging 13:5 (1995), 661–674.
47. Kallur, T., Farr, T.D., Bohm-Sturm, P., Kokaia, Z., Hoehn, M., Spatio-temporal dynamics, differentiation and viability of human neural stem cells after implantation into neonatal rat brain. The European Journal of Neuroscience 34:3 (2011), 382–393.
48. Kao, Y.Y., Cheng, T.J., Yang, D.M., Wang, C.T., Chiung, Y.M., Liu, P.S., Demonstration of an olfactory bulb-brain translocation pathway for ZnO nanoparticles in rodent cells in vitro and in vivo. Journal of Molecular Neuroscience 48:2 (2012), 464–471.
49. Kong, S.D., Lee, J., Ramachandran, S., Eliceiri, B.P., Shubayev, V.I., Lal, R., Jin, S., Magnetic targeting of nanoparticles across the intact blood-brain barrier. Journal of Controlled Release 164:1 (2012), 49–57.
50. Li, S.D., Huang, L., Pharmacokinetics and biodistribution of nanoparticles. Molecular Pharmaceutics 5:4 (2008), 496–504.
51. Li, T., Murphy, S., Kiselev, B., Bakshi, K.S., Zhang, J., Eltahir, A.,.. Dorn, H.C., A new interleukin-13 amino-coated gadolinium metallofullerene nanoparticle for targeted MRI detection of glioblastoma tumor cells. Journal of the American Chemical Society 137:24 (2015), 7881–7888.
52. Liu, Y., Gao, Y., Liu, Y., Li, B., Chen, C., Wu, G., Oxidative stress and acute changes in murine brain tissues after nasal instillation of copper particles with different sizes. Journal of Nanoscience and Nanotechnology 14:6 (2014), 4534–4540.
53. Liu, Y., Guan, W., Ren, G., Yang, Z., The possible mechanism of silver nanoparticle impact on hippocampal synaptic plasticity and spatial cognition in rats. Toxicology Letters 209:3 (2012), 227–231.
54. Locatelli, E., Naddaka, M., Uboldi, C., Loudos, G., Fragogeorgi, E., Molinari, V.,.. Franchini, M.C., Targeted delivery of silver nanoparticles and alisertib: In vitro and in vivo synergistic effect against glioblastoma. Nanomedicine (London, England) 9:6 (2014), 839–849.
55. Lundqvist, M., Stigler, J., Cedervall, T., Berggard, T., Flanagan, M.B., Lynch, I.,.. Dawson, K., The evolution of the protein corona around nanoparticles: A test study. ACS Nano 5:9 (2011), 7503–7509.
56. Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., Dawson, K.A., Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proceedings of the National Academy of Sciences of the United States of America 105:38 (2008), 14265–14270.
57. Mae, M., Armulik, A., Betsholtz, C., Getting to know the cast—Cellular interactions and signaling at the neurovascular unit. Current Pharmaceutical Design 17:26 (2011), 2750–2754.
58. Mathiisen, T.M., Lehre, K.P., Danbolt, N.C., Ottersen, O.P., The perivascular astroglial sheath provides a complete covering of the brain microvessels: An electron microscopic 3D reconstruction. Glia 58:9 (2010), 1094–1103.
59. Merkus, F.W.H.M., Schipper, N.G.M., Verhoef, J.C., The influence of absorption enhancers on intranasal insulin absorption in normal and diabetic subjects. Journal of Controlled Release 41:1–2 (1996), 69–75.
60. Mistry, A., Stolnik, S., Illum, L., Nanoparticles for direct nose-to-brain delivery of drugs. International Journal of Pharmaceutics 379:1 (2009), 146–157.
61. Monopoli, M.P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Bombelli, F.B., Dawson, K.A., Physical-chemical aspects of protein corona: Relevance to in vitro and in vivo biological impacts of nanoparticles. Journal of the American Chemical Society 133:8 (2011), 2525–2534.
62. Moraes, L., Vasconcelos-dos-Santos, A., Santana, F.C., Godoy, M.A., Rosado-de-Castro, P.H., Jasmin, J.,.. Mendez-Otero, R., Neuroprotective effects and magnetic resonance imaging of mesenchymal stem cells labeled with SPION in a rat model of Huntington's disease. Stem Cell Research 9:2 (2012), 143–155.
63. Muldoon, L.L., Sandor, M., Pinkston, K.E., Neuwelt, E.A., Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor. Neurosurgery 57:4 (2005), 785–796 discussion 785–796.
64. Murillo, T.P., Sandquist, C., Jacobs, P.M., Nesbit, G., Manninger, S., Neuwelt, E.A., Imaging brain tumors with ferumoxtran-10, a nanoparticle magnetic resonance contrast agent. Therapy 2 (2005), 871–882.
65. Na, H.B., Lee, J.H., An, K., Park, Y.I., Park, M., Lee, I.S.,.. Hyeon, T., Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angewandte Chemie (International Ed. in English) 46:28 (2007), 5397–5401.
66. Nabeshima, S., Reese, T.S., Landis, D.M., Brightman, M.W., Junctions in the meninges and marginal glia. The Journal of Comparative Neurology 164:2 (1975), 127–169.
67. Nag, S., Morphology and properties of brain endothelial cells. Methods in Molecular Biology 686 (2011), 3–47.
68. Nel, A., Xia, T., Madler, L., Li, N., Toxic potential of materials at the nanolevel. Science 311:5761 (2006), 622–627.
69. Nellore, J., Pauline, C., Amarnath, K., Bacopa monnieri phytochemicals mediated synthesis of platinum nanoparticles and its neurorescue effect on 1-methyl 4-phenyl 1,2,3,6 tetrahydropyridine-induced experimental parkinsonism in zebrafish. Journal of Neurodegenerative Diseases, 2013, 2013, 972391.
70. Neuwelt, E.A., Varallyay, P., Bago, A.G., Muldoon, L.L., Nesbit, G., Nixon, R., Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. Neuropathology and Applied Neurobiology 30:5 (2004), 456–471.
71. Pardridge, W.M., Drug and gene targeting to the brain via blood–brain barrier receptor-mediated transport systems. International Congress Series 1277 (2005), 49–62.
72. Pardridge, W.M., Drug targeting to the brain. Pharmaceutical Research 24:9 (2007), 1733–1744.
73. Park, J.Y., Baek, M.J., Choi, E.S., Woo, S., Kim, J.H., Kim, T.J.,.. Lee, G.H., Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: Account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images. ACS Nano 3:11 (2009), 3663–3669.
74. Prades, R., Guerrero, S., Araya, E., Molina, C., Salas, E., Zurita, E.,.. Giralt, E., Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor. Biomaterials 33:29 (2012), 7194–7205.
75. Pujals, S., Fernandez-Carneado, J., Lopez-Iglesias, C., Kogan, M.J., Giralt, E., Mechanistic aspects of CPP-mediated intracellular drug delivery: Relevance of CPP self-assembly. Biochimica Et Biophysica Acta-Biomembranes 1758:3 (2006), 264–279.
76. Ramos-Gómez, M., Martinez-Serrano, A., Tracking of iron-labeled human neural stem cells by magnetic resonance imaging in cell replacement therapy for Parkinson's disease. Neural Regeneration Research 11:1 (2016), 49–52.
77. Ramos-Gómez, M., Seiz, E.G., Martinez-Serrano, A., Optimization of the magnetic labeling of human neural stem cells and MRI visualization in the hemiparkinsonian rat brain. Journal of Nanobiotechnology, 13, 2015, 20.
78. Saddick, S., Afifi, M., & Abu Zinada, O. A. (in press). Effect of zinc nanoparticles on oxidative stress-related genes and antioxidant enzymes activity in the brain of Oreochromis niloticus and Tilapia zillii. Saudi Journal of Biological Sciences.
79. Saiyed, Z.M., Gandhi, N.H., Nair, M.P.N., Magnetic nanoformulation of azidothymidine 5'-triphosphate for targeted delivery across the blood-brain barrier. International Journal of Nanomedicine 5 (2010), 157–166.
80. Sakulkhu, U., Maurizi, L., Mahmoudi, M., Motazacker, M., Vries, M., Gramoun, A.,.. Hofmann, H., Ex situ evaluation of the composition of protein corona of intravenously injected superparamagnetic nanoparticles in rats. Nanoscale 6:19 (2014), 11439–11450.
81. Schaffler, M., Sousa, F., Wenk, A., Sitia, L., Hirn, S., Schleh, C.,.. Krol, S., Blood protein coating of gold nanoparticles as potential tool for organ targeting. Biomaterials 35:10 (2014), 3455–3466.
82. Schultke, E., Menk, R., Pinzer, B., Astolfo, A., Stampanoni, M., Arfelli, F.,.. Nikkhah, G., Single-cell resolution in high-resolution synchrotron X-ray CT imaging with gold nanoparticles. Journal of Synchrotron Radiation 21:Pt. 1 (2014), 242–250.
83. Shao, C., Li, S., Gu, W., Gong, N., Zhang, J., Chen, N.,.. Ye, L., Multifunctional gadolinium-doped manganese carbonate nanoparticles for targeted MR/fluorescence imaging of tiny brain gliomas. Analytical Chemistry 87:12 (2015), 6251–6257.
84. Shilo, M., Motiei, M., Hana, P., Popovtzer, R., Transport of nanoparticles through the blood-brain barrier for imaging and therapeutic applications. Nanoscale 6:4 (2014), 2146–2152.
85. Shultz, M.D., Wilson, J.D., Fuller, C.E., Zhang, J., Dorn, H.C., Fatouros, P.P., Metallofullerene-based nanoplatform for brain tumor brachytherapy and longitudinal imaging in a murine orthotopic xenograft model. Radiology 261:1 (2011), 136–143.
86. Simon, G.H., von Vopelius-Feldt, J., Fu, Y., Schlegel, J., Pinotek, G., Wendland, M.F.,.. Daldrup-Link, H.E., Ultrasmall supraparamagnetic iron oxide-enhanced magnetic resonance imaging of antigen-induced arthritis: A comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol. Investigative Radiology 41:1 (2006), 45–51.
87. Sintov, A.C., Levy, H.V., Botner, S., Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies. Journal of Controlled Release 148:2 (2010), 168–176.
88. Soto, C., Sigurdsson, E.M., Morelli, L., Kumar, R.A., Castano, E.M., Frangione, B., Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy. Nature Medicine 4:7 (1998), 822–826.
89. Sousa, F., Mandal, S., Garrovo, C., Astolfo, A., Bonifacio, A., Latawiec, D.,.. Krol, S., Functionalized gold nanoparticles: A detailed in vivo multimodal microscopic brain distribution study. Nanoscale 2:12 (2010), 2826–2834.
90. Taschner, C.A., Wetzel, S.G., Tolnay, M., Froehlich, J., Merlo, A., Radue, E.W., Characteristics of ultrasmall superparamagnetic iron oxides in patients with brain tumors. AJR. American Journal of Roentgenology 185:6 (2005), 1477–1486.
91. Tenzer, S., Docter, D., Rosfa, S., Wlodarski, A., Kuharev, J., Rekik, A.,.. Stauber, R.H., Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: A comprehensive quantitative proteomic analysis. ACS Nano 5:9 (2011), 7155–7167.
92. Thorne, R.G., Emory, C.R., Ala, T.A., Frey, W.H. 2nd., Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Research 692:1–2 (1995), 278–282.
93. Thu, M.S., Najbauer, J., Kendall, S.E., Harutyunyan, I., Sangalang, N., Gutova, M.,.. Aboody, K.S., Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model. PLoS One, 4(9), 2009, e7218.
94. Tosi, G., Bortot, B., Ruozi, B., Dolcetta, D., Vandelli, M.A., Forni, F., Severini, G.M., Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier. Current Medicinal Chemistry 20:17 (2013), 2212–2225.
95. Tsai, M.C., Chen, Y.H., Chiang, L.Y., Polyhydroxylated C60, fullerenol, a novel free-radical trapper, prevented hydrogen peroxide- and cumene hydroperoxide-elicited changes in rat hippocampus in-vitro. The Journal of Pharmacy and Pharmacology 49:4 (1997), 438–445.
96. Ugwoke, M.I., Agu, R.U., Verbeke, N., Kinget, R., Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives. Advanced Drug Delivery Reviews 57:11 (2005), 1640–1665.
97. Varallyay, C.G., Nesbit, E., Fu, R., Gahramanov, S., Moloney, B., Earl, E., Neuwelt, E.A., High-resolution steady-state cerebral blood volume maps in patients with central nervous system neoplasms using ferumoxytol, a superparamagnetic iron oxide nanoparticle. Journal of Cerebral Blood Flow and Metabolism 33:5 (2013), 780–786.
98. Velasco-Aguirre, C., Morales, F., Gallardo-Toledo, E., Guerrero, S., Giralt, E., Araya, E., Kogan, M.J., Peptides and proteins used to enhance gold nanoparticle delivery to the brain: Preclinical approaches. International Journal of Nanomedicine 10 (2015), 4919–4936.
99. Wadghiri, Y.Z., Li, J., Wang, J., Hoang, D.M., Sun, Y., Xu, H.,.. Wisniewski, T., Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging. PLoS One, 8(2), 2013, e57097.
100. Wang, G., Zhang, X., Skallberg, A., Liu, Y., Hu, Z., Mei, X., Uvdal, K., One-step synthesis of water-dispersible ultra-small Fe3O4 nanoparticles as contrast agents for T1 and T2 magnetic resonance imaging. Nanoscale 6:5 (2014), 2953–2963.
101. Wen, Z., Yan, Z., Hu, K., Pang, Z., Cheng, X., Guo, L.,.. Lai, R., Odorranalectin-conjugated nanoparticles: Preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration. Journal of Controlled Release 151:2 (2011), 131–138.
102. Wiley, D.T., Webster, P., Gale, A., Davis, M.E., Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor. Proceedings of the National Academy of Sciences of the United States of America 110:21 (2013), 8662–8667.
103. Wolfe, T.R., Bernstone, T., Intranasal drug delivery: An alternative to intravenous administration in selected emergency cases. Journal of Emergency Nursing 30:2 (2004), 141–147.
104. Wu, Y.N., Chen, D.H., Shi, X.Y., Lian, C.C., Wang, T.Y., Yeh, C.S.,.. Shieh, D.B., Cancer-cell-specific cytotoxicity of non-oxidized iron elements in iron core-gold shell NPs. Nanomedicine (London, England) 7:4 (2011), 420–427.
105. Wu, J., Ding, T., Sun, J., Neurotoxic potential of iron oxide nanoparticles in the rat brain striatum and hippocampus. Neurotoxicology 34 (2013), 243–253.
106. Yin, N., Yao, X., Zhou, Q., Faiola, F., Jiang, G., Vitamin E attenuates silver nanoparticle-induced effects on body weight and neurotoxicity in rats. Biochemical and Biophysical Research Communications 458:2 (2015), 405–410.
107. Yin, N., Zhang, Y., Yun, Z., Liu, Q., Qu, G., Zhou, Q.,.. Jiang, G., Silver nanoparticle exposure induces rat motor dysfunction through decrease in expression of calcium channel protein in cerebellum. Toxicology Letters 237:2 (2015), 112–120.
108. Ze, Y., Zheng, L., Zhao, X., Gui, S., Sang, X., Su, J.,.. Hong, F., Molecular mechanism of titanium dioxide nanoparticles-induced oxidative injury in the brain of mice. Chemosphere 92:9 (2013), 1183–1189.
109. Zhang, D., Fa, H.B., Zhou, J.T., Li, S., Diao, X.W., Yin, W., The detection of beta-amyloid plaques in an Alzheimer's disease rat model with DDNP-SPIO. Clinical Radiology 70:1 (2015), 74–80.